Triple Murder In Bangladesh .Daughter Killed Father , Mother And Sister in Capital city .

Girl name Mehjabin allegedly arrested for triple murder

 Police of Kadamtoli  , recovered bodies of a couple and their daughter from Muradpur in Kadamtoli area of the capital.

Elder daughter of the family Mehzabin Islam Moon has confessed to police in primary interrogation that she killed her family over a dispute. 

The three deceased were identified by relatives and police as Masud Rana, 50, his wife Mousumi Akter, 45, and their daughter Jannat, 18.

Meanwhile, sensational information has started to be leaked after Mehjabin was held.

According to relatives and locals, Mehjabin got married first in Keraniganj. She had been arrested in a case filed over her husband murder. She also served jail for five years in the case. Her parents were also sent to jail in the case. Later, she got married Shafiqul Islam Aranya.

Police quoted Mehazabin as saying that she had long been angry with her family members.

“Mehzabin claims her mother forced both the sisters into sex work in the absence of their father. After her marriage, she asked her mother to stop forcing her sister but the mother did not,” he added.

He further said Mehazabin claimed her younger sister was having an extramarital affair with her husband.

 

Indian doctors use antibody therapy to treat covid-19 patients successfully .

 Doctors of Sir Ganga Ram Hospital in New Delhi have successfully treated patients suffering from Covid-19 using monoclonal antibody therapy. The two patients who were administered the REGCov2, designed to produce resistance against the SARS-CoV-2, were discharged within 12 hours of being given the doses.

Monoclonal antibodies are identical copies of an antibody that targets one specific antigen. This treatment has previously been used in treating deadly pathogens like Ebola and HIV. The REGCov2 is developed by Regeneron which is conducting the phase-3 Covid-19 prevention trials.

Dr Pooja Khosla, senior consultant, department of medicine, SGRH said that the two patients who were given the antibody  were a 36-year-old healthcare worker, who was suffering from high-grade fever, cough, myalgia, severe weakness and low blood cell count, while the other was an 80-year man with comorbidities including diabetes and hypertension.

While Razdan's oxygen saturation was more than 95 per cent, a CT scan confirmed the presence of mild Covid-19. The doctors administered REGCov2 on both the patients, who showed a significant change in parameters within the next 12 hours. Source :India Today .

Pfizer begins COVID vaccine trials for children 5 to 11 years of age .

Pfizer announced it's expanding its clinical trials for younger children ages 5 to 11-years-old. 

 

 Pfizer announced it's expanding its clinical trials for younger children ages 5 to 11-years-old. Medical doctors are calling this the final frontier.

This is a 2-year study, where a subset of the children enrolled in the trial will receive the COVID-19 vaccine, and a second group will receive a placebo or salt water as part of the Phase 2/3 trials. The Pfizer vaccine injected in children is the same as the one injected in adults, but the dosage will be less.

Pfizer's trial is focused on detecting the antibody response to the COVID-19 vaccine, and verifying if a lower dosage produces enough immunity for this group. Children 5 to 11-years-old will be injected with 10 micro grams in each dose, as opposed to 30 micro grams those 12 and older received.

Dr. Yvone Maldonado is the principal investigator at Stanford University School of Medicine for the Pfizer trial. Dr. Maldonado said they've received an influx of interested families.

The End Of Israeli PM Benjamin Netanyahu Era : Opponents announced to Oust him .

Benjamin Netanyahu

 

The opponents of Israeal  announced Wednesday that they had reached an agreement to form a government and oust him from office, in all likelihood spelling the end of Benjamin Netanyahu era .

Centrist lawmaker Yair Lapid said in a statement that he had informed Israeli President Reuven Rivlin he had succeeded in forming a coalition government with Naftali Bennett, a former defense minister and onetime Netanyahu ally, as well as other parties.

Bennett, a former settler leader who shares many of Netanyahu’s hard-line views and heads the small religious Yamina party, is due to serve as prime minister for two years before handing over the reins to Lapid for two more.

But Mr. Netanyahu signaled early Thursday that he would not go down without a struggle, calling on lawmakers to oppose “this dangerous left-wing government.”

While he appeared to have few avenues to hang onto power, Mr. Netanyahu’s career has been marked by a keen instinct for political survival.

Under the last-minute agreement by a coalition of opposition parties,Naftali Bennett,  who opposes a Palestinian state and is a standard-bearer for religious nationalists, will serve as prime minister until 2023.

Should the new government hold together that long, the deal then calls for him to be replaced by Yair Lapid, a centrist former television host considered a standard-bearer for secular Israelis. Mr. Lapid would serve the remaining two years of the coalition’s term.